Find side effects reporting information at the bottom of this page 
If you are a UK Healthcare Professional, please visit our Healthcare Professional website here
This website is for UK members of the public, patients prescribed Boehringer Ingelheim medicines and their carers.

Chronic Kidney Disease

ckd-patient-banner

Chronic Kidney Disease

Chronic Kidney Disease

Chronic Kidney Disease, abbreviated as CKD, is a condition that affects the kidneys and is characterised by the gradual loss of kidney function over time. CKD typically develops slowly and may go unnoticed in its early stages, emphasising the importance of regular kidney function monitoring. In the UK, there are an estimated 7.19 million people living with chronic kidney disease, more than 10% of the entire population, and numbers are still increasing rapidly1.

CKD is often categorised into stages based on the severity of kidney damage, with stage 1 being the mildest and stage 5 representing the most advanced form of the disease, also referred to as end-stage renal disease (ESRD). Approximately 3.25 million of these people are living with CKD stages 3-51.

Risk factors for CKD in the UK can be diverse, including high blood pressure, diabetes, and a genetic predisposition to kidney issues. As CKD advances, it impairs the kidneys' ability to filter waste and excess fluids from the blood, leading to complications such as high blood pressure, anaemia, bone problems, and fluid retention in the body. CKD, like diabetes, can result in long-term medical implications particularly relevant to the Cardio-Renal-Metabolic system such as heart disease, stroke, and end-stage kidney disease.

References

Where can I find more information?

Patient Information Leaflet

The Patient Information Leaflet is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using this medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

If you are in the United Kingdom, click the below link to access this information

Summary of Product Characteristics

The Summary of Product Characteristics tells healthcare professionals, such as doctors, pharmacists and nurses, how to prescribe and use this medicine correctly. The information in the Patient Information Leaflet and Summary of Product Characteristics are not intended to replace the opinion of a healthcare professional.

If you are in the United Kingdom, click the below link to access this information

NP-GB-103857 V3 | December 2024

picture of man typing on laptop

Side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any side effects not listed in package leaflet.
You can also report side effects directly to the Yellow Card scheme
of www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of the medicine.